Table 4.
Control | i.p. SD | Oral SD | Oral FD | |
---|---|---|---|---|
Volumetric density (%) | ||||
Intertubule | 11.20 ± 0.41 | 12.25 ± 1.50 | 11.88 ± 1.12 | 11.26 ± 1.07 |
Connective tissue | 0.70 ± 0.19ª | 0.92 ± 0.17ª | 1.36 ± 0.25b | 0.94 ± 0.17ª |
Lymphatic space | 0.92 ± 0.43 | 0.42 ± 0.24 | 0.56 ± 0.11 | 0.87 ± 0.51 |
Blood vessel | 1.92 ± 0.48 | 1.79 ± 0.42 | 1.22 ± 0.41 | 1.51 ± 0.42 |
Macrophage | 0.23 ± 0.02ª | 0.50 ± 0.21b | 0.78 ± 0.20b | 0.60 ± 0.19b |
Leydig cytoplasm | 6.09 ± 0.53ab | 7.06 ± 1.05b | 6.22 ± 0.37ª | 5.84 ± 0.23ª |
Leydig nucleus | 1.33 ± 0.25ª | 1.56 ± 0.25ab | 1.74 ± 0.18b | 1.50 ± 0.18ab |
Leydig cell | 7.42 ± 0.75 | 8.62 ± 1.30 | 7.96 ± 0.54 | 7.34 ± 0.35 |
Volume (mL) | ||||
Intertubule | 0.023 ± 0.001ab | 0.025 ± 0.002ª | 0.022 ± 0.005ab | 0.019 ± 0.002b |
Connective tissue | 0.0014 ± 0.0004ª | 0.0019 ± 0.0003ªb | 0.0024 ± 0.0006b | 0.0016 ± 0.0003ª |
Lymphatic space | 0.0019 ± 0.0009 | 0.0009 ± 0.0005 | 0.0010 ± 0.0003 | 0.0015 ± 0.0009 |
Blood vessel | 0.0038 ± 0.0008ª | 0.0037 ± 0.0009ª | 0.0022 ± 0.0010b | 0.0026 ± 0.0008ªb |
Macrophage | 0.0005 ± 0.0001ª | 0.0010 ± 0.0005ab | 0.0014 ± 0.0004b | 0.0010 ± 0.0003b |
Leydig cytoplasm | 0.0123 ± 0.0014ª | 0.0144 ± 0.0014b | 0.0110 ± 0.0018ac | 0.099 ± 0.0005c |
Leydig nucleus | 0.0027 ± 0.0004 | 0.0032 ± 0.0004 | 0.0031 ± 0.0006 | 0.0025 ± 0.0003 |
Leydig cell | 0.0150 ± 0.0016ª | 0.0176 ± 0.0017b | 0.0141 ± 0.0024a | 0.0124 ± 0.0007a |
Mean ± SDM (standard deviation of the mean); control: distilled water; i.p. SD = CdCl2 intraperitoneal single dose; oral SD: CdCl2 oral single dose; oral FD: CdCl2 oral fractionated dose. abDifferent letters in the same row, for each evaluated time, indicate significant differences by the Student-Newman-Keuls test (p ≤ 0.05).